藤田 昌樹 ふじた まさき 先生

来歴等

略歴

1988.6－1989.5 　九州大学医学部附属病院医員　研修医（呼吸器科）
1989.6－1990.5 　九州厚生年金病院　臨床研修医
1990.6－1991.3 　九州大学医学部附属病院　医員（呼吸器科）
1995.10－1996.5 西福岡病院　医師
1997.3－1999.8 　National Jewish Medical and Research Center, Research Associate
1990.9－2000.3 　 北九州市立医療センター　呼吸器科部長
2000.4－2003.9 　九州大学医学部附属病院　助手（呼吸器科）
2004.4－2007.3 　九州大学病院呼吸器科　助手（講師併任）　　　　　　　　　　　　　　　　　　　　　　　
2007.4－2007.9 　九州大学病院呼吸器科　講師
2007.10－2010.9　福岡大学医学部呼吸器内科学　准教授（福岡大学病院呼吸器内科副診療部長）
2010.10－2017.3　　　　 福岡大学病院呼吸器内科　診療教授（内視鏡部副部長兼務）
2017.4－現在　　　　　 福岡大学病院呼吸器内科　主任教授

論文

○1 Fujita M, Amako K:
Localization of the sapA gene on a physical map of Campylobacter fetus
Chromosomal DNA.
Arch Microbiol 162(6): 375-380, 1994

○2 Fujita M, Fujimoto S, Morooka T, Amako K:
Analysis of strains of Campylobacter fetus by pulsed-field gel
electrophoresis.
J Clin Microbiol 33(6): 1676-1678, 1995

○3 Fujita M, Moriya T, Fujimoto S, Hara N, Amako K:
A deletion in the sapA homologue cluster is responsible for the loss
of the S-layer in Campylobacter fetus strain TK.
Arch Microbiol 167(4): 196-201, 1997

○4 Fujita M, Kuwano K, Kunitake R, Hagimoto N, Miyazaki H, Kaneko Y, Kawasaki M, Maeyama T, Hara N:
Endothelial cell apoptosis in lipopolysaccharide-induced lung injury in mice.
Int Arch Allergy Immunol 117(3): 202-208, 1998

○5 Fujita M, JM Shannon, CG Irvin, KA Fagan, C Cool, A Augustin, RJ Mason:
Overexpression of TNF-alpha produces an increase in lung volumes and pulmonary hypertension.
Am J Physiol Lung Cell Mol Physiol 280: L39-L49, 2001

○6 Fujita M, Mason RJ, Cool C, JM Shannon JM, Hara N, Fagan KA:
Pulmonary hypertension in TNF-alpha overexpressing mice is associated with decreased VEGF gene expression.
J Appl Physiol 93: 2162-2170, 2002

○7 Fujita M, Shannon JM, Morikawa O, Gauldie J, Hara N, Mason RJ: Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta.
Am J Respir Cell Mol Biol 29(6): 669-676, 2003

○8 Fujita M, Ye Q, Ouchi H, Nakashima, Hamada N, Hagimoto N, Kuwno K,
Mason RJ, Nakanishi N:
Retinoic acid failed to reverse emphysema in adult mouse model.
Thorax 59(3): 224-230, 2004

○9 Fujita M, Q Ye, H Ouchi, E Harada, I Inoshima, K Kuwano,
Nakanishi Y :
Doxycycline attenuated pulmonary fibrosis induced by bleomycin in mice
Antimicrob Agents Chemothe 50: 739-743. 2006

○10 Fujita M, Harada E, Ikegame S, Ye Q, Ouchi H, Inoshima I, Kuwano K,
Nakanishi Y :
Doxycycline attenuated lung injury by its biological effect apart from its antimicrobial function.
Pulm Pharmacol Ther 20: 669-675, 2007

○11 Fujita M, Ikegame S, Ye Q, Harada E, Ouchi H, Inoshima I,
Watanabe K, Mason RJ, Nakanishi Y :
Attenuation of pulmonary hypertension, but not emphysematous change,
by breeding emphysema model mice at sea level.
Cytokine 41(3): 286-292, 2008

○12 Fujita M, Ikegame S, Harada E, Ouchi H, Inoshima I, Watanabe K,
Yoshida S, Nakanishi Y :
TNF receptor 1 and 2 contribute in different ways to resistance to Legionella pneumophila-induced mortality in mice.
Cytokine 44: 298-303, 2008

○13 Fujita M, Harada, E, Matsumoto T, Yuichi M, Ikegame S, Ouchi H,
Inoshima I, Yoshida S, Watanabe K, Nakanishi Y :
Impaired host defense against Mycobacterium avium in mice with chronic granulomatous disease.
Clin Exp Immunol 160:457-460, 2010

○14 Fujita M, Tokunaga S, Ikegame S, Harada E, Matsumoto T, Uchino J,
Watanabe K, Nakanishi Y:
Identifying risk factors for refractory febrile neutropenia in patients with lung cancer.
J Infect Chemother 18: 53-58, 2012

○15 Fujita M, Kajiki A, Tao Y, Miyazaki M, Ouchi H, Harada E, Ikegame S,
Matsumoto T, Uchino J, Watanabe K, Nakanishi Y:
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
J Infect Chemother 18: 146-151, 2012

〇16 Tashiro N, Fujita M, Matsumoto T, Hirano R, Uchino J, Harada E, Ikegame S, Ouchi H, Nakanishi Y, Watanabe K.
Doxycycline Attenuated Mycobacterium avium Induced Inflammation in Mice. Mycobacterial Diseases. 5;1000192, 2015

〇17 Fujita M, Matsumoto T, Hirano R, Ouchi H, Harada E, Nakanishi Y, Watanabe K.
Carbohydrate antigen 19-9 (CA19-9) represents the disease activity of nontuberculous mycobacteria.
Mycobacterial Diseases. 5;1000195, 2015

〇18 Fujita M, Matsumoto T, Hirano R, Ishii K, Hiromatsu K, Uchino J, Watanabe K.
Attenuation of pulmonary Mycobacterium avium disease by active hexose correlated compound (AHCC) in mice.
J Nutr Disorders Ther. 5:1000174, 2015

その他

• 【受賞】2000年11月 日本呼吸器学会九州支部会奨励賞　COPDモデルとしてのTNFトランスジェニックマウス

• 【受賞】2004年10月 日本界面医学会奨励賞　慢性炎症におけるSP-Dの役割　

• 【受賞】2007年11月 日本感染症学会西日本地方会　感染症優秀論文賞

• 【受賞】Doxycycline attenuated pulmonary fibrosis induced by bleomycin in mice.

• 【受賞】2011年11月 Best Oral Presentation Award 2011 16th Congress of the Asian Pacific Society of Respirology

• 【受賞】2013年4月 日本内科学会　Awards for Outstanding Reviewers